Latest news from 17 organisations in the Arab region
The European Commission has approved the first disease-modifying therapy, ocrelizumab, for early primary progressive MS (PPMS).
Helmut Butzkueven, who led the development of MSBase with support from MS Research Australia, has received the Data Innovation Award.
Third annual meeting (Encuentro) brings together MS organisations from 16 Latin American countries to share learnings and work towards shared solutions to common challenges.
More than 900 health professionals and representatives from 38 countries gathered in Dubai for MENACTRIMS 2017, which featured a special joint session with MSIF.
This year marked the 50th anniversary of the MS International Federation, giving us a valuable opportunity to celebrate shared successes and renew our commitment to work together to achieve a world without MS.
Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health
Cold water in the mouth can help reduce heat sensitivity, a common symptom of MS.
Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that drain blood from the brain and spinal cord over a prolonged period.
Study reveals important mechanism that allows immune cells to attack myelin in MS
A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s advocacy work to increase funding for MSSNs
Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between the two organisations